| AMP | antimicrobial peptide |
| APTES | (3-aminopropyl)-triethoxysilane |
| Asp | asparagine |
| BBT | bromelain-based treatment |
| CDTA | cyclohexane-1,2-diaminoetetraacetic acid |
| COX-2 | prostaglandin-endoperoxide synthase 2 |
| CP | cysteine proteinase |
| DETA | diethylenetriamine |
| Dha | dehydroalanine |
| Dhb | dehydrobutyrine |
| ECM | extracellular matrix |
| EDC | 1-ethyl-(3-dimethylaminopropyl) carbodiimide |
| EDTA | ethylenediaminetetraacetic acid |
| EMA | European Medicines Agency |
| GA | glutaraldehyde |
| HEDTA | hydroxyethyl ethylenediamine triacetic acid |
| IL | interleukin |
| Lan | lanthionine |
| LD50 | lethal dose |
| Leu | leucine |
| Km | Michaelis–Menten constant |
| MBC | minimum bactericidal concentration |
| MeLan | β-methyl lanthionine |
| MIC | minimum inhibitory concentration |
| MRSA | methicillin-resistant Staphylococcus aureus |
| MSN | mesoporous silica nanoparticles |
| NCBI | National Center for Biotechnology Information |
| NF-κB | Nuclear factor kappa B |
| NHS | N-hydroxysuccinimide |
| PC | phosphatidylcholine |
| PEG | poly(ethylene glycol) |
| PEHA | pentaethylenehexamine |
| PET | polyethylene terephthalate |
| PGE-2 | prostaglandin E2 |
| PGI-2 | prostaglandin I2 |
| pI | isoelectric point |
| PS | polystyrene |
| SEM | scanning electron microscopy |
| SPRA | self-assembly PEGylation retaining activity |
| TEPA | tetraethylenepentamine |
| TETA | triethylenetetramine |
| TNF | tumour necrosis factor |
| TXA-2 | thromboxane A2 |
| Vmax | maximum reaction velocity |
| Val | valine |